Correlation Between Inhibikase Therapeutics and Nuvation Bio
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Nuvation Bio, you can compare the effects of market volatilities on Inhibikase Therapeutics and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Nuvation Bio.
Diversification Opportunities for Inhibikase Therapeutics and Nuvation Bio
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inhibikase and Nuvation is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Nuvation Bio go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Nuvation Bio
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 1.37 times more return on investment than Nuvation Bio. However, Inhibikase Therapeutics is 1.37 times more volatile than Nuvation Bio. It trades about 0.16 of its potential returns per unit of risk. Nuvation Bio is currently generating about -0.02 per unit of risk. If you would invest 138.00 in Inhibikase Therapeutics on August 28, 2024 and sell it today you would earn a total of 96.00 from holding Inhibikase Therapeutics or generate 69.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Nuvation Bio
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Nuvation Bio |
Inhibikase Therapeutics and Nuvation Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Nuvation Bio
The main advantage of trading using opposite Inhibikase Therapeutics and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Nuvation Bio vs. Eliem Therapeutics | Nuvation Bio vs. Scpharmaceuticals | Nuvation Bio vs. Milestone Pharmaceuticals | Nuvation Bio vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |